Allspring Global Investments Holdings LLC acquired a new stake in shares of Amrize Ltd (NYSE:AMRZ - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,264,210 shares of the company's stock, valued at approximately $62,646,000.
Wall Street Analysts Forecast Growth
A number of research analysts recently weighed in on the company. Royal Bank Of Canada reduced their price objective on Amrize from $61.00 to $54.00 and set an "outperform" rating for the company in a research report on Friday, August 8th. Zacks Research raised Amrize from a "strong sell" rating to a "hold" rating in a research report on Friday, October 10th. Barclays assumed coverage on Amrize in a research report on Tuesday, October 7th. They set an "equal weight" rating for the company. JPMorgan Chase & Co. raised their price objective on Amrize from $52.00 to $60.00 and gave the company an "overweight" rating in a research report on Tuesday, August 26th. Finally, Oppenheimer started coverage on Amrize in a report on Tuesday, September 9th. They issued an "outperform" rating and a $62.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Amrize presently has a consensus rating of "Moderate Buy" and a consensus price target of $57.00.
Read Our Latest Report on AMRZ
Amrize Price Performance
Amrize stock opened at $48.97 on Wednesday. The business has a fifty day simple moving average of $50.61. Amrize Ltd has a 12 month low of $44.12 and a 12 month high of $56.29. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.38 and a quick ratio of 0.85.
Amrize (NYSE:AMRZ - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.78 EPS for the quarter, missing analysts' consensus estimates of $1.03 by ($0.25). The business had revenue of $3.22 billion during the quarter.
Insider Transactions at Amrize
In related news, CFO Ian A. Johnston bought 10,500 shares of the stock in a transaction that occurred on Friday, August 8th. The shares were bought at an average cost of $47.71 per share, for a total transaction of $500,955.00. Following the completion of the transaction, the chief financial officer owned 17,344 shares of the company's stock, valued at approximately $827,482.24. This trade represents a 153.42% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jan Philipp Jenisch bought 545,000 shares of the stock in a transaction that occurred on Monday, August 11th. The shares were bought at an average price of $47.96 per share, for a total transaction of $26,138,200.00. Following the completion of the transaction, the chief executive officer directly owned 1,450,000 shares of the company's stock, valued at $69,542,000. This represents a 60.22% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 1,124,000 shares of company stock worth $53,225,260.
Amrize Profile
(
Free Report)
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Further Reading
Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.